ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ALRN Aileron Therapeutics Inc

3,13
0,09 (2,96%)
22 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aileron Therapeutics Inc ALRN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 2,96% 3,13 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,04 2,80 3,20 3,13 3,04
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
05.6.202412:58EDGAR2Form 8-K - Current report
16.5.202423:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
16.5.202423:01EDGAR2Form 8-K - Current report
15.5.202423:16EDGAR2Form 8-K - Current report
15.5.202423:13GLOBEAileron Therapeutics Reports First Quarter 2024 Financial..
15.5.202423:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202422:05GLOBEAileron Therapeutics to Present at Two Upcoming Investor..
03.5.202422:05GLOBEAileron Therapeutics Announces Closing of Underwritten..
01.5.202414:45GLOBEAileron Therapeutics Announces Pricing of Underwritten..
01.5.202414:30GLOBEAileron Therapeutics Announces Positive Data from Cohort 1..
15.4.202423:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12.3.202413:00GLOBEAileron Therapeutics Announces CEO Transition
06.3.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202413:01EDGAR2Form 8-K - Current report
15.2.202422:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13.2.202413:01EDGAR2Form 8-K - Current report
06.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05.2.202419:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202422:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
31.1.202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29.1.202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.1.202422:10EDGAR2Form S-3 - Registration statement under Securities Act of..
29.1.202414:46EDGAR2Form DEF 14A - Other definitive proxy statements
29.1.202414:14EDGAR2Form 8-K - Current report
25.1.202413:00EDGAR2Form 8-K - Current report
19.1.202422:44EDGAR2Form PRE 14A - Other preliminary proxy statements
11.1.202422:18EDGAR2Form 8-K/A - Current report: [Amend]
10.1.202422:08EDGAR2Form 8-K - Current report
18.12.202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03.11.202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202301:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.11.202301:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.10.202317:40EDGAR2Form 8-K - Current report
31.10.202317:30PRNUSAileron Therapeutics Announces Acquisition of Lung..
13.10.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]